))
Leukemia Edition: Top Headlines for Week of March 27, 2023
Manage episode 407442278 series 3560281
Content provided by Healio. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Healio or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.
In this edition, optimal antibiotics timing among inpatients with cancer; inflammation levels linked to survival in acute myeloid leukemia; dexrazoxane confers long-term cardioprotection for pediatric cancer and more. Read the full coverage here:
Optimal antibiotics timing ‘likely differs’ among inpatients with cancer, neutropenic fever
Inflammation levels linked to survival in acute myeloid leukemia
Dexrazoxane confers long-term cardioprotection after anthracyclines for pediatric cancer
Menin inhibitor produces high response rates in certain acute leukemia subtypes
Tisa-cel CAR-T reinfusion lacks durability for younger patients with B-cell ALL
References:
Chow EJ, et al. J Clin Oncol. 2023;doi:10.1200/JCO.22.02423.
Issa GC, et al. Nature. 2023;doi:10.1038/s41586-023-05812-3.
Krupski C, et al. Abstract LBA4. Presented at: Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR, Feb. 15-19, 2023; Orlando.
Lasry A, et al. Nat Cancer. 2022;doi:10.1038/s43018-022-00480-0. Villars J, et al. Am J Med Qual. 2023;doi:10.1097/JMQ.0000000000000093.
105 episoade
Distribuie
